Wednesday, 18 April 2012

Method for selecting inhibitors of Rm1A...

St Andrews University have applied for patent relating to an invention which provides a purified and crystallised form of RmlA and its X-ray structure. In addition, it also provides a method of selecting agents which inhibit the enzyme RmlA, such as, providing a model of the active or regulatory site (s) of RmlA; reviewing the structure of a potential inhibitory agent for at least one of these sites; analysing the potential interaction of said agent in said site (s).

This technology may prove to be of substantial benefit to pharmaceutical and biotechnology companies, to select for anti-microbial compounds for further development. For example, an anti-bacterial or anti-fungal agent which binds to an active or regulatory site of RmlA sufficiently tightly to impede the biosynthesis of rhamnose and thus growth of the micro-organism.